To examine whether TNKS1BP1 affects cellular response to chemotherapeutic drugs, we tested the influence of TNKS1BP1 on the sensitivity of human lung cancer cell line, A549 to two DNA damage reagents cisplatin and bleomycin. This evidence concerns the gene CNOT12 and lung carcinoma.